FARYDAK

This brand name is authorized in Austria, Estonia, France, Croatia, Ireland, Japan, Lithuania, Netherlands, Poland, Romania, Singapore, United Kingdom, United States

Active ingredients

The drug FARYDAK contains one active pharmaceutical ingredient (API):

1 Panobinostat UNII HN0T99OO4V - PANOBINOSTAT LACTATE

Panobinostat is a histone deacetylase (HDAC) inhibitor that inhibits the enzymatic activity of HDACs at nanomolar concentrations. HDACs catalyse the removal of acetyl groups from the lysine residues of histones and some non-histone proteins. Inhibition of HDAC activity results in increased acetylation of histone proteins, an epigenetic alteration that results in a relaxing of chromatin, leading to transcriptional activation. Read about Panobinostat

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
FARYDAK Hard capsule	European Medicines Agency (EU)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01XH03	Panobinostat	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XH Histone deacetylase (HDAC) inhibitors
Discover more medicines within L01XH03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1696068, 1696079, 1696080, 1696091, 1696103, 1696114, 1696125, 1696136, 1696147
Country: FR	Base de données publique des médicaments	Identifier(s): 60937038, 62990388, 65638805
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 324036, 324044, 324047
Country: JP	医薬品医療機器総合機構	Identifier(s): 4291040M1023, 4291040M2020
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1077849, 1077850, 1077851, 1077852, 1077853, 1077854, 1077855, 1077856, 1077857
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 128708, 128716, 128724
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100350004, 100350091, 100350100
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W66904001, W66904002, W66904003, W66905001, W66905002, W66905003, W66906001, W66906002, W66906003
Country: SG	Health Sciences Authority	Identifier(s): 15071P, 15072P, 15073P
Country: US	FDA, National Drug Code	Identifier(s): 0078-0650, 0078-0651, 0078-0652, 73116-100, 73116-101, 73116-102